Identify Battery Solvent Impurities Using GC-MS for High-Performance Lithium-Ion Batteries

Dimethyl carbonate (DMC) is a major compound found in lithium-ion battery electrolytes. In these solvent formulations, purity is directly correlated with performance, safety, and lifetime. Even trace-level impurities can accelerate the degradation of solid electrolyte interfaces, promote lithium-ion consumption, or trigger gas formation. Each of these processes can negatively affect both efficiency and safety.

As battery materials continue to advance, analytical approaches must offer high sensitivity alongside reliable, accurate identification of material composition. A recent LECO study showed that using two GC-MS platforms in parallel enables a more comprehensive characterization of DMC impurities than either platform alone.

Pegasus BTX.

Pegasus BTX. Image Credit: LECO Corporation

Why Impurity Characterization in DMC is Challenging 

The analysis of battery-grade solvents requires the ability to identify contaminants across an extensive concentration range, starting from dominant byproducts to trace-level species. In DMC, impurities may take the form of oxygenated compounds, hydrocarbons, and nitriles, the majority of which derive from handling or synthesis processes.

These compounds can co-elute or be present at levels that can evade typical detection thresholds, making it difficult to acquire a complete analysis using a single analytical technique. Moreover, electron ionization (EI) spectra do not always deliver a clear molecular ion, making it increasingly difficult to validate which compounds are present.

Pegasus GC-HRT.

Pegasus GC-HRT. Image Credit: LECO Corporation

A Complementary Analytical Strategy: Sensitivity and Confidence

LECO’s recent study put forward a combined workflow using the following analytical techniques:

  • Pegasus BTX (GC-TOFMS) for high-sensitivity detection
  • Pegasus HRT (high-resolution GC-MS) for accurate mass confirmation

The Pegasus BTX facilitates impurity detection below parts-per-billion levels, ensuring the capture of low-abundance analytes.

After running detection protocols, the Pegasus HRT offered high-resolution, precision mass data in both EI and positive chemical ionization (PCI) modes. PCI was shown to be of considerable value when EI spectra do not exhibit a distinct molecular ion, as it allows validation through common adduct species, including protonated molecular ions [M+H]+.

Moreover, it is not necessary to make hardware changes to access both ionization modes, meaning the workflow enables efficient, multi-dimensional confirmation of analyte identity.

Observations 

By taking a combined approach, various classes of impurities were detected in the DMC sample. These included:

  • Alcohols, carbonates, and ethers
  • Hydrocarbons and aromatic species
  • Oxygenated reaction byproducts
  • Supplementary low-level analytes detected with high library match scores

Crucially, the high sensitivity of the Pegasus BTX meant the researchers were able to determine an extensive set of low-concentration compounds, while the Pegasus HRT boosted researchers' confidence in compound identification via accurate mass measurements and verification of molecular formulas.

The study also shed light on those cases where co-eluting compounds were effectively deconvoluted, enabling the identification of individual components even without complete chromatographic separation.

Why This Matters for Battery Materials Analysis 

This work highlights a key principle for the characterization of advanced materials: the detection and identification present significant challenges that generally require integrated solutions.

  • Detection alone remains insufficient without confident identification
  • High-resolution confirmation is limited if low-level species are not initially detected

Therefore, laboratories can gain an enhanced understanding of a solvent’s purity, the production processes, and any potential performance risks in battery systems by combining the capabilities of complementary analytical strategies.

Explore the Complete Study 

This short overview details only a portion of the key findings. The full study provides:

  • Chromatographic and spectral data examples
  • Comprehensive acquisition parameters and workflows
  • Examples that demonstrate EI/PCI complementarity and accurate mass confirmation
  • Verified impurity lists with retention times and similarity scores

To gain deeper insights into how complementary GC-MS techniques can boost confidence in battery solvent analysis, download the full application note below.

Image

This information has been sourced, reviewed and adapted from materials provided by LECO Corporation.

For more information on this source, please visit LECO Corporation.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    LECO Corporation. (2026, August 11). Identify Battery Solvent Impurities Using GC-MS for High-Performance Lithium-Ion Batteries. AZoM. Retrieved on August 11, 2026 from https://www.azom.com/article.aspx?ArticleID=25456.

  • MLA

    LECO Corporation. "Identify Battery Solvent Impurities Using GC-MS for High-Performance Lithium-Ion Batteries". AZoM. 11 August 2026. <https://www.azom.com/article.aspx?ArticleID=25456>.

  • Chicago

    LECO Corporation. "Identify Battery Solvent Impurities Using GC-MS for High-Performance Lithium-Ion Batteries". AZoM. https://www.azom.com/article.aspx?ArticleID=25456. (accessed August 11, 2026).

  • Harvard

    LECO Corporation. 2026. Identify Battery Solvent Impurities Using GC-MS for High-Performance Lithium-Ion Batteries. AZoM, viewed 11 August 2026, https://www.azom.com/article.aspx?ArticleID=25456.

Ask A Question

Do you have a question you'd like to ask regarding this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.